These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 111408
1. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology. Petrescu A, Mihail A, Samuel I, Teodosiu O, Isaia G, Ganea E, Motaş C. Virologie; 1979; 30(2):109-15. PubMed ID: 111408 [Abstract] [Full Text] [Related]
6. Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine. Ainai A, Tamura S, Suzuki T, Ito R, Asanuma H, Tanimoto T, Gomi Y, Manabe S, Ishikawa T, Okuno Y, Odagiri T, Tashiro M, Sata T, Kurata T, Hasegawa H. J Med Virol; 2012 Feb; 84(2):336-44. PubMed ID: 22170556 [Abstract] [Full Text] [Related]
9. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z. J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461 [Abstract] [Full Text] [Related]
11. The presence of interferon and type A immunoglobulins in the nasopharyngeal secretions of volunteers immunized with an inactivated influenza vaccine. Danielescu G, Barbu C, Sorodoc Y, Cajal N, Sărăteanu D. Acta Virol; 1975 May; 19(3):245-9. PubMed ID: 239580 [Abstract] [Full Text] [Related]
12. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE. Vaccine; 2012 Jan 05; 30(2):466-74. PubMed ID: 22051136 [Abstract] [Full Text] [Related]
13. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus]. Crifò S, Filiaci F, Pelosio A, Rocchi G. Boll Soc Ital Biol Sper; 1978 Jun 15; 54(11):1021-6. PubMed ID: 743410 [No Abstract] [Full Text] [Related]
14. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Ambrose CS, Wu X, Jones T, Mallory RM. Vaccine; 2012 Nov 06; 30(48):6794-801. PubMed ID: 23000125 [Abstract] [Full Text] [Related]
17. [Problems of specific secretory antiviral immunity]. Shvartsman IaS. Usp Sovrem Biol; 1976 Nov 06; 81(3):429-44. PubMed ID: 788388 [No Abstract] [Full Text] [Related]
18. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization. Avtushenko SS, Sorokin EM, Zoschenkova NY, Zacharova NG, Naichin AN. J Biotechnol; 1996 Jan 26; 44(1-3):21-8. PubMed ID: 8717382 [Abstract] [Full Text] [Related]